Reedman Cassandra N, Duffield Todd F, DeVries Trevor J, Lissemore Kerry D, Winder Charlotte B
Department of Population Medicine, University of Guelph, Guelph, ON, N1G 2W1 Canada.
Department of Animal Biosciences, University of Guelph, Guelph, ON, N1G 2W1 Canada.
JDS Commun. 2021 Sep 13;2(6):376-380. doi: 10.3168/jdsc.2021-0121. eCollection 2021 Nov.
Calfhood morbidity is an important issue on commercial dairy operations, with substantial production and welfare impacts. The objective of this observational study was to evaluate potential risk factors for morbidity, including disbudding, disbudding pain control, serum total protein (STP) concentrations, and haptoglobin concentrations in young dairy calves. A total of 140 heifer calves from a commercial dairy farm in southwestern Ontario, Canada, were enrolled at 1 to 9 d of age and followed for 1 wk. Calves were scored at enrollment for several health parameters using a scale from 0 to 3, with 0 representing normal and 3 representing severely abnormal. Calves were only included if they were considered healthy enough to participate using cut points of <3 for rectal temperature and fecal score; ≤2 for nasal discharge, ocular discharge, and cough score; and 1 for ear position, navel score, and joint score. To ensure that only calves that were considered healthy on the baseline day were included, 17 calves were excluded from analysis, resulting in a total of 123 calves. These calves were a part of a disbudding trial, with 100 disbudded using a commercial caustic paste and 23 sham disbudded with a placebo paste. The disbudding paste (commercial or sham) was applied to calves on enrollment day (baseline) with health scoring at baseline and 3 and 7 d later. The following health outcomes were analyzed: diarrhea (a fecal consistency score of ≥2), respiratory disease (a total respiratory score of ≥5), and general sickness [suffering from either diarrhea, respiratory disease, or a navel or joint infection (joint or navel score of ≥2)]. The following variables were assessed for association with the outcomes: STP, inadequate transfer of passive immunity (<5.2 g/dL STP), pain control treatment for disbudding (lidocaine nerve block alone, meloxicam alone, lidocaine nerve block and meloxicam, no pain control, sham), disbudding (disbudded or sham), and haptoglobin concentrations (taken on the baseline day, +3 d and +7 d). We did not detect any relationship between the development of a health outcome of interest (diarrhea, respiratory, or sick) and disbudding or pain control on any of the days following disbudding. However, for every 1 g/dL increase in STP concentration, calves had 0.24 and 0.33 times the odds of suffering from diarrhea or any sickness event, respectively, 3 d after disbudding. At 3 d after disbudding, for every 0.1 mg/mL increase in haptoglobin concentration on that day, calves had 1.34 and 1.20 times the odds of having diarrhea or a general sickness, respectively. These findings suggest that disbudding itself or the pain control method does not appear to influence health after the procedure when healthy calves are disbudded. Calves developing an illness 3 d after disbudding were more likely to have had lower STP concentrations and increased haptoglobin concentrations.
犊牛期发病是商业化奶牛养殖中的一个重要问题,对生产和福利有重大影响。这项观察性研究的目的是评估发病的潜在风险因素,包括去角、去角疼痛控制、血清总蛋白(STP)浓度以及幼龄奶牛犊的触珠蛋白浓度。来自加拿大安大略省西南部一个商业化奶牛场的140头小母牛犊在1至9日龄时入组,并跟踪1周。在入组时使用0至3的评分标准对犊牛的几个健康参数进行评分,0代表正常,3代表严重异常。仅当犊牛的直肠温度和粪便评分<3;鼻分泌物、眼分泌物和咳嗽评分≤2;耳位、脐部评分和关节评分=1,被认为健康到足以参与时才纳入。为确保仅纳入基线日被认为健康的犊牛,17头犊牛被排除在分析之外,最终共有123头犊牛。这些犊牛是一项去角试验的一部分,其中100头使用商用苛性糊剂去角,23头用安慰剂糊剂进行假去角。在入组日(基线)给犊牛涂抹去角糊剂(商用或假用),并在基线、3天和7天后进行健康评分。分析了以下健康结果:腹泻(粪便稠度评分≥2)、呼吸系统疾病(总呼吸评分≥5)和一般疾病[患有腹泻、呼吸系统疾病或脐部或关节感染(关节或脐部评分≥2)]。评估了以下变量与这些结果的关联:STP、被动免疫转移不足(STP<5.2 g/dL)、去角的疼痛控制治疗(单独使用利多卡因神经阻滞、单独使用美洛昔康、利多卡因神经阻滞和美洛昔康、无疼痛控制、假处理)、去角(去角或假去角)以及触珠蛋白浓度(在基线日、+3天和+7天采集)。我们未发现去角后任何一天感兴趣的健康结果(腹泻、呼吸系统疾病或患病)的发生与去角或疼痛控制之间存在任何关系。然而,去角后3天,STP浓度每增加1 g/dL,犊牛患腹泻或任何疾病事件的几率分别为0.24倍和0.33倍。去角后3天,当日触珠蛋白浓度每增加0.1 mg/mL,犊牛患腹泻或一般疾病的几率分别为1.34倍和1.20倍。这些发现表明,当对健康犊牛进行去角时,去角本身或疼痛控制方法似乎不会影响术后健康。去角后3天患病的犊牛更可能STP浓度较低且触珠蛋白浓度升高。